首页> 外文期刊>海南医科大学学报(英文版) >Plasma miR-182 expression in non-small cell lung cancer and its relationship with tumor CT findings and malignant biological molecule expression
【24h】

Plasma miR-182 expression in non-small cell lung cancer and its relationship with tumor CT findings and malignant biological molecule expression

机译:血浆miR-182在非小细胞肺癌中的表达及其与肿瘤CT表现和恶性生物分子表达的关系

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To study the plasma miR-182 expression in non-small cell lung cancer and its relationship with tumor CT findings and malignant biological molecule expression.Methods:A total of 60 patients who were diagnosed with non-small cell lung cancer in our hospital from May 2012 to October 2015 were included in NSCLC group of the study, and 80 cases of healthy volunteers who received physical examination in our hospital during the same period and whose general data matched with that of NSCLC patients were included in control group of the study. Contrast-enhanced CT was conducted and the major diameter and minor diameter of lesions were measured, plasma was collected to determine miR-182 expression as well as CEA, CYFRA21-1, SCC-Ag and TSGF levels, and tumor tissue was collected to determine the content of RECK, MTSS1, PDCD4 and DNMT3a.Results: Relative plasma miR-182 expression of NSCLC group was significantly higher than that of control group; axial maximum major diameter, maximum minor diameter perpendicular to it and coronary maximum vertical major diameter in non-small cell lung cancer patients with high plasma miR-182 expression were significantly higher than those in non-small cell lung cancer patients with low plasma miR-182 expression, plasma CEA, CYFRA21-1, SCC-Ag and TSGF levels were significantly higher than those in non-small cell lung cancer patients with low plasma miR-182 expression, RECK, MTSS1, PDCD4 and DNMT3a levels in tumor tissue were significantly lower than those in non-small cell lung cancer patients with low plasma miR-182 expression, and differences in above indexes between two groups were statistically significant (P<0.05).Conclusions: Plasma miR-182 expression is abnormally high in non-small cell lung cancer and is closely related to the CT findings of tumor, the content of serum tumor markers and the expression of malignant molecules in tumor tissue.
机译:目的:研究非小细胞肺癌中的血浆miR-182表达及其与肿瘤CT结果和恶性生物分子表达的关系。方法:共有60名患者在我们院内诊断出非小细胞肺癌从2012年5月到2015年10月,纳入了NSCLC集团的研究,以及80例健康志愿者在同一时期内接受了体检,其与NSCLC患者的一般数据符合该研究的对照组。进行了对比度增强的CT,测量病变的主直径和小直径,收集血浆以确定miR-182表达以及CEA,CyFRA21-1,SCC-AG和TSGF水平,并收集肿瘤组织以确定RECK,MTSS1,PDCD4和DNMT3A的含量:NSCLC组的相对血浆MIR-182表达明显高于对照组;轴向最大直径,垂直于血浆miR-182表达的非小细胞肺癌患者的最大小直径和冠状动脉最大垂直直径显着高于非小型细胞肺癌患者低等离子体miR- 182表达,血浆CEA,CYFRA21-1,SCC-AG和TSGF水平明显高于非小型细胞肺癌患者的低血浆MIR-182表达,RECK,MTS1,PDCD4和DNMT3A水平显着显着低于血浆miR-182表达低的非小细胞肺癌患者的患者,两组之间的上述指标的差异有统计学意义(P <0.05)。结论:血浆miR-182表达在非小的异常高细胞肺癌和肿瘤CT发现密切相关,血清肿瘤标志物的含量及肿瘤组织中恶性分子的表达。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2016年第15期|121-124|共4页
  • 作者单位

    Cancer Center of No. 187 Hospital of Chinese PLA, Haikou City, Hainan Province, 571159, China;

    Cancer Center of No. 187 Hospital of Chinese PLA, Haikou City, Hainan Province, 571159, China;

    Cancer Center of No. 187 Hospital of Chinese PLA, Haikou City, Hainan Province, 571159, China;

    Cancer Center of No. 187 Hospital of Chinese PLA, Haikou City, Hainan Province, 571159, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:42:18
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号